


The investment objective of CF Eclectica Continental European Fund is to achieve long-term capital growth.
| Name | % Net Assets |
|---|---|
| 30 Year German Bund | 16.5% |
| France Telecom | 5.9% |
| Koninklijke KPN | 5.7% |
| British American Tobacco | 5.5% |
| Imperial Tobacco | 5.5% |
| Roche | 4.4% |
| Deutsche Telekom | 4.3% |
| Syngenta | 4.2% |
| Novo Nordisk | 3.8% |
| SES Global | 3.7% |
| Key | % Net Assets |
|---|---|
| 16.5% | |
| 5.9% | |
| 5.7% | |
| 5.5% | |
| 66.4% |
| Date | n/a |
|---|---|
| Bid | 0.00 |
| Offer | 0.00 |
| Currency | n/a |
| Change | 0.00 |
| % | n/a |
| YTD change | 0.00 |
| YTD % | n/a |
| Fund Inception | 03/04/2006 |
|---|---|
| Fund Manager | n/a |
| TER | - |
| Minimum Investment | |
|---|---|
| Initial | 5000 |
| Additional | n/a |
| Savings | 150 |
| Charges | |
|---|---|
| Initial | n/a |
| Annual Mang't | 1.75% |
| Exit | n/a |
| Name | % |
|---|---|
| No risk data available. | |
You are here: research